Variant report

Variant	rs34771575
Chromosome Location	chr2:85929674-85929675
allele	CA/TG
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr2:85839135..85840661-chr2:85928083..85930394,2	MCF-7	breast:
2	chr2:85928909..85931848-chr2:86021884..86024213,2	K562	blood:

Variant related genes	Relation type
ENSG00000168883	Chromatin interaction
ENSG00000168887	Chromatin interaction

Extended variants
information (count: 48 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:39)

rs_ID	r²[population]
rs10180391	0.92[ASN][1000 genomes]
rs10187314	0.81[ASN][1000 genomes]
rs10187495	0.87[ASN][1000 genomes]
rs10206121	0.92[ASN][1000 genomes]
rs10210321	0.87[ASN][1000 genomes]
rs11127	0.87[ASN][1000 genomes]
rs12620113	0.90[ASN][1000 genomes]
rs12845	0.87[ASN][1000 genomes]
rs13389847	0.88[ASN][1000 genomes]
rs13408224	0.87[ASN][1000 genomes]
rs1437742	0.87[ASN][1000 genomes]
rs1437743	0.87[ASN][1000 genomes]
rs1437744	0.87[ASN][1000 genomes]
rs1837115	0.92[ASN][1000 genomes]
rs1866138	0.86[ASN][1000 genomes]
rs1866139	0.83[ASN][1000 genomes]
rs1866140	0.86[ASN][1000 genomes]
rs1866141	0.87[ASN][1000 genomes]
rs2070966	0.86[ASN][1000 genomes]
rs2118402	0.85[ASN][1000 genomes]
rs2366807	0.87[ASN][1000 genomes]
rs2886767	0.84[ASN][1000 genomes]
rs2886768	0.89[ASN][1000 genomes]
rs34218330	0.88[ASN][1000 genomes]
rs34702373	0.92[ASN][1000 genomes]
rs3755007	0.83[ASN][1000 genomes]
rs4240200	0.92[ASN][1000 genomes]
rs4240201	0.86[ASN][1000 genomes]
rs4240202	0.87[ASN][1000 genomes]
rs4832185	0.87[ASN][1000 genomes]
rs4832187	0.96[AMR][1000 genomes];1.00[EUR][1000 genomes];0.94[ASN][1000 genomes]
rs55665393	0.90[ASN][1000 genomes]
rs59832218	0.90[ASN][1000 genomes]
rs61191323	0.87[ASN][1000 genomes]
rs62163092	0.90[ASN][1000 genomes]
rs6740635	0.90[ASN][1000 genomes]
rs7585576	0.90[ASN][1000 genomes]
rs7908	0.87[ASN][1000 genomes]
rs880872	0.88[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:9 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv874459	chr2:85828014-85939207	Flanking Active TSS Strong transcription Weak transcription Enhancers Genic enhancers Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA	27 gene(s)	inside rSNPs	diseases
2	nsv874460	chr2:85828014-85941074	Enhancers Weak transcription Transcr. at gene 5' and 3' Strong transcription Genic enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA	27 gene(s)	inside rSNPs	diseases
3	nsv874461	chr2:85853653-85939207	Flanking Active TSS Weak transcription Strong transcription Genic enhancers Bivalent Enhancer Enhancers Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA	10 gene(s)	inside rSNPs	diseases
4	nsv874462	chr2:85853653-85941074	Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Enhancers Strong transcription Active TSS Genic enhancers Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA	10 gene(s)	inside rSNPs	diseases
5	nsv874463	chr2:85853653-85946708	Strong transcription Bivalent Enhancer Enhancers Weak transcription Active TSS Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA	10 gene(s)	inside rSNPs	diseases
6	nsv874465	chr2:85898898-85939207	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Active TSS Genic enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Strong transcription	TF binding region CpG island Chromatin interactive region lncRNA	6 gene(s)	inside rSNPs	diseases
7	nsv874466	chr2:85909026-85939207	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Genic enhancers Strong transcription	TF binding region CpG island Chromatin interactive region lncRNA	5 gene(s)	inside rSNPs	diseases
8	nsv874467	chr2:85916487-85946708	Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Bivalent/Poised TSS Strong transcription Transcr. at gene 5' and 3' Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA	5 gene(s)	inside rSNPs	diseases
9	nsv874468	chr2:85926598-86001255	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Genic enhancers Active TSS Bivalent/Poised TSS Strong transcription Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA	6 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:52 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:85922000-85931400	Weak transcription	Lung	lung
2	chr2:85924600-85932200	Weak transcription	Spleen	Spleen
3	chr2:85925600-85930400	Weak transcription	Primary B cells from peripheral blood	blood
4	chr2:85926000-85931600	Weak transcription	Primary hematopoietic stem cells	blood
5	chr2:85926000-85931600	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
6	chr2:85926000-85932400	Weak transcription	Primary T killer naive cells fromperipheralblood	blood
7	chr2:85926000-85945200	Enhancers	Primary monocytes fromperipheralblood	blood
8	chr2:85926600-85932000	Weak transcription	K562	blood
9	chr2:85926800-85930200	Weak transcription	Primary hematopoietic stem cells short term culture	blood
10	chr2:85927200-85932400	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
11	chr2:85927400-85929800	Weak transcription	Primary neutrophils fromperipheralblood	blood
12	chr2:85928000-85930400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
13	chr2:85928000-85930600	Enhancers	ES-I3 Cell Line	embryonic stem cell
14	chr2:85928000-85930600	Enhancers	NHDF-Ad	bronchial
15	chr2:85928000-85934800	Enhancers	Hela-S3	cervix
16	chr2:85928200-85929800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
17	chr2:85928200-85930000	Enhancers	HUES6 Cell Line	embryonic stem cell
18	chr2:85928200-85930000	Enhancers	NHLF	lung
19	chr2:85928200-85930200	Enhancers	ES-WA7 Cell Line	embryonic stem cell
20	chr2:85928200-85930200	Enhancers	iPS-15b Cell Line	embryonic stem cell
21	chr2:85928200-85930200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
22	chr2:85928200-85930200	Enhancers	HMEC	breast
23	chr2:85928400-85930200	Enhancers	Muscle Satellite Cultured Cells	--
24	chr2:85928400-85930200	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
25	chr2:85928400-85930400	Enhancers	HSMM	muscle
26	chr2:85928400-85930400	Enhancers	NHEK	skin
27	chr2:85928800-85929800	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
28	chr2:85928800-85929800	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
29	chr2:85928800-85930000	Enhancers	HUES64 Cell Line	embryonic stem cell
30	chr2:85928800-85930000	Enhancers	HUVEC	blood vessel
31	chr2:85928800-85930000	Enhancers	Osteobl	bone
32	chr2:85928800-85930200	Enhancers	iPS-18 Cell Line	embryonic stem cell
33	chr2:85928800-85930200	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
34	chr2:85928800-85930200	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
35	chr2:85929000-85929800	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
36	chr2:85929000-85930000	Weak transcription	H9 Cell Line	embryonic stem cell
37	chr2:85929000-85930200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
38	chr2:85929000-85932000	Weak transcription	Psoas Muscle	Psoas
39	chr2:85929000-85932000	Enhancers	GM12878-XiMat	blood
40	chr2:85929000-85932400	Weak transcription	Breast Myoepithelial Primary Cells	Breast
41	chr2:85929200-85929800	Enhancers	Monocytes-CD14+_RO01746	blood
42	chr2:85929200-85930200	Enhancers	iPS-20b Cell Line	embryonic stem cell
43	chr2:85929200-85930600	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
44	chr2:85929400-85929800	Weak transcription	HSMMtube	muscle
45	chr2:85929400-85930000	Flanking Active TSS	A549	lung
46	chr2:85929400-85930200	Enhancers	NH-A	brain
47	chr2:85929400-85930600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
48	chr2:85929600-85930000	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
49	chr2:85929600-85930200	Enhancers	H1 Cell Line	embryonic stem cell
50	chr2:85929600-85930200	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links